{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_000177485.3:c.2565A>T",
          "cDNA Change": {
            "transcript": "NM_000177485.3",
            "ref": "A",
            "alt": "T",
            "position": "2565"
          },
          "Protein Change": {
            "ref": "N",
            "alt": "N",
            "position": "855"
          },
          "Description in input context": "pathogenic mutations increase the tendency of dardarin to form inclusion bodies"
        },
        {
          "HGVS": "NM_000177485.3:c.2565A>T",
          "cDNA Change": {
            "transcript": "NM_000177485.3",
            "ref": "A",
            "alt": "T",
            "position": "2565"
          },
          "Protein Change": {
            "ref": "N",
            "alt": "N",
            "position": "855"
          },
          "Description in input context": "pathogenic muta- phenotypes associated with mutant dardarin. Manipulating activity by kinase inhibition provides neuroprotective effects."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's Disease",
    "MONDO": "MONDO:0003936"
  },
  "Experiment Method": [
    {
      "Assay Method": "In vitro kinase assay",
      "Material used": {
        "Material Source": "Recombinant protein",
        "Material Name": "dardarin",
        "Description": "Recombinant dardarin protein was used for kinase activity assays."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000177485.3:c.2565A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "kinase inhibition provides neuroprotective effects",
          "Result Description": "Kinase activity was reduced when using kinase inhibitors."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "No",
        "Description": "No information about biological replicates."
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": "No information about technical replicates."
      },
      "Basic positive control": {
        "Basic positive control": "No",
        "Description": "No information about a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "No",
        "Description": "No information about a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "No information about statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Not specified in literature",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Kinase activity significantly reduced with inhibitors",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}